Trimethoprim
| Trimethoprim | |
|---|---|
| Trimethoprim.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Trimethoprim is an antibiotic used primarily in the treatment of urinary tract infections, although it is also used for other types of bacterial infections. It is often used in combination with sulfamethoxazole as co-trimoxazole.
Mechanism of action[edit]
Trimethoprim works by inhibiting the bacterial enzyme dihydrofolate reductase, which is involved in the synthesis of tetrahydrofolate, a form of folic acid that bacteria need to produce DNA, RNA, and proteins. By blocking this enzyme, trimethoprim effectively halts bacterial growth.
Uses[edit]
Trimethoprim is primarily used to treat urinary tract infections, but it is also effective against other types of infections such as respiratory tract infections and traveler's diarrhea. It is often used in combination with sulfamethoxazole to enhance its antibacterial effect.
Side effects[edit]
Common side effects of trimethoprim include nausea, vomiting, and rash. More serious side effects can include bone marrow suppression, which can lead to anemia, leukopenia, and thrombocytopenia.
Resistance[edit]
Bacterial resistance to trimethoprim can occur through various mechanisms, including the production of an altered dihydrofolate reductase enzyme that is not inhibited by the drug. Resistance is a growing concern, particularly in the treatment of urinary tract infections.
History[edit]
Trimethoprim was first synthesized in the 1960s and was introduced into clinical use in the 1970s. It has since become a widely used antibiotic, particularly in combination with sulfamethoxazole.
Related pages[edit]
References[edit]
-
Chemical structure of Trimethoprim -
3D ball model of Trimethoprim from hydrochloride crystal -
Wild-type Staphylococcus aureus DHFR in complex with NADPH and Trimethoprim -
Tetrahydrofolate synthesis pathway
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
